Midbrain dopaminergic neurons in the mouse: Co-localization with calbindin-D(28K) and calretinin

Neuroscience

Volumn 75, Issue 2, 1996, Pages 523-533

  Liang, C L ^a   Sinton, C M ^a   German, D C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

calcium binding proteins; immunoytochemistry; tyrosine hydroxylase

Indexed keywords

CALBINDIN; CALRETININ; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MALE; MESENCEPHALON; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030601734     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00228-X     Document Type: Article

References (54)

1. Arai R., Winsky L., Arai M., Jacobowitz D.M. Immunohistochemical localization of calretinin in the rat hindbrain. J. comp. Neurol. 310:1991;21-44.
2. 28k and parvalbumin in the rat nervous system. Neuroscience. 35:1990;375-475.
3. Dahlstrom A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta physiol. scand. Suppl. 232:1962;1-31.
4. Fallon J., Moore R.Y. Catecholamine innervation of the basal forebrain: IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. comp. Neurol. 180:1978;545-580.
5. Fuller R.W., Steranka L.R. Central and peripheral catecholamine depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in rodents. Life Sci. 36:1985;243-247.
6. Garcia-Segura L.M., Baetens D., Roth J., Norman A.W., Orci L. Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res. 296:1984;75-86.
7. Gerfen C.R., Baimbridge K.G., Thibault J. The neostriatal mosaic: compartmental distribution of CaBP and parvalbumin in the basal ganglia of the rat and monkey. Proc. natn. Acad. Sci. U.S.A. 82:1985;8780-8784.
8. Gerfen C.R., Herkenham M., Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7:1987;3915-3934.
9. Gerfen C.R., Herkenham M., Thibault J. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci. 7:1987;3935-3944.
10. German D.C., Dubach M., Askari S., Speciale S.G., Bowden D.M. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost? Neuroscience. 24:1988;161-174.
11. 28k. NeuroReport. 4:1993;491-494.
12. German D.C., Manaye K.F. Midbrain dopaminergic neurons (nuclei A8, A9 and A10): three-dimensional reconstruction in the rat. J. comp. Neurol. 331:1993;297-309.
13. German D.C., Manaye K.F., Brown J., Gerfen C.R. Calcium-binding protein immunoreactivity in the human midbrain: relationship to dopaminergic neurons. Neurosci. Abstr. 16:1990;696.
14. German D.C., Manaye K.F., Smith W.K., Woodward D.J., Saper C.B. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann. Neurol. 26:1989;507-514.
15. 28k-containing cells. Ann. N.Y. Acad. Sci. 648:1992;42-62.
16. German D. C., Nelson E. L., Liang C.-L., Speciale S. G., Sinton C. R. and Sonsalla P. K. (1996) The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration, submitted.
17. Hallman H., Large J., Olson L., Stromberg I., Jonsson G. Neurochemical and histochemical characterization of neurotoxic effects of MPTP on brain catecholamine neurons in the mouse. J. Neurochem. 44:1985;117-127.
18. Heikkila R.E., Hess A., Duvoisin R.C. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice. Science. 224:1984;1451-1453.
19. 2+-binding proteins in human neurodegenerative disorders. TINS. 15:1992;259-264.
20. Heppelmann B., Senaris R., Emson P.C. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons. Brain Res. 635:1994;293-299.
21. Hokfelt T., Everitt B.J., Theodorsson-Norheim E., Goldstein M. Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. J. comp. Neurol. 222:1984;543-559.
22. Hokfelt T., Skirboll L., Rehfeld J.F., Goldstein K., Markey K., Dann O. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience. 5:1980;2093-2124.
23. 28k-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity. Molec. Brain Res. 13:1992;251-261.
24. Isaacs K.R., Jacobowitz D.M. Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area. Expl Brain Res. 99:1994;34-42.
25. Lavoie B., Parent A. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. NeuroReport. 2:1991;601-604.
26. 28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration, submitted.
27. 3-MPTP) induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies. Brain Res. 491:1989;307-315.
28. 28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience. 65:1995;87-91.
29. McRitchie D.A., Hardman C.D., Halliday G.M. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J. comp. Neurol. 364:1996;121-150.
30. Miettinen R., Gulyas A.I., Baimbridge K.G., Jacobowitz D.M., Freund T.F. Calretinin is present in non-pyramidal cells of the rat hippocampus. II. Co-existence with other calcium binding proteins and GABA. Neuroscience. 48:1992;29-43.
31. Mouatt-Prigent A., Agid Y., Hirsch E.C. Does the calcium-binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease? Brain Res. 668:1994;62-70.
32. Nelson E. L., Liang C.-L., Sinton C. M. and German, D. C. (1996) Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J. comp. Neurol. in press.
33. 28k levels in mouse midbrain dopaminergic neurons. Molec. Brain Res. in press.
34. Olszewski J. and Baxter D. (1954) Cytoarchitecture of the Human Brain Stem. Karger, Basel.
35. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
36. Persechini A., Moncrief N.D., Kretsinger R.H. The EF-hand family of calcium-modulated proteins. Trends Neurosci. 12:1989;462-467.
37. Resibois A., Rogers J.H. Calretinin in rat brain: an immunohistochemical study. Neuroscience. 46:1992;101-134.
38. Rogers J.H. Two calcium-binding proteins mark many chick sensory neurons. Neuroscience. 31:1989;697-709.
39. Rogers J.H. Immunoreactivity for calretinin and other calcium-binding proteins in cerebellum. Neuroscience. 31:1989;711-721.
40. Rogers J.H. Calretinin: a gene for a novel calcium-binding protein-expressed principally in neurons. J. Cell Biol. 105:1989;1343-1353.
41. 28k with neuropeptides and GABA. Brain Res. 587:1992;147-157.
42. 28k with tyrosine hydroxylase. Brain Res. 587:1992;203-210.
43. 28k in rat brain: patterns of partial co-localization. Neuroscience. 51:1992;843-865.
44. 28k- and parvalbumin-reacting neurons in the hypothalamic magnocellular neurosecretory nuclei of the rat. Brain Res. Bull. 28:1991;39-46.
45. Sanghera M.K., Manaye K.F., Liang C.-L., Iacopino A.M., Bannon M.J., German D.C. Low dopamine transporter mRNA levels in midbrain regions containing calbindin. NeuroReport. 5:1994;1641-1644.
46. 28k. Neurosci. Abstr. 21:1995;1380.
47. Schwaller B., Buchwald P., Blumcke I., Celio M.R., Hunziker W. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin. Cell Calcium. 14:1993;639-648.
48. Seress L., Nitsch R., Leranth C. Calretinin immunoreactivity in the monkey hippocampal formation. I. Light and electron microscopic characteristics and co-localization with other calcium-binding proteins. Neuroscience. 55:1993;775-796.
49. Seroogy K.B., Mehta A., Fallon J.H. Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain. Expl Brain Res. 68:1987;277-289.
50. Seroogy K., Ceccatelli S., Schalling M., Hokfelt T., Frey P., Walsh J., Dockray G., Brown J., Buchan A., Goldstein M. A subpopulation of dopaminergic neurons in the rat ventral mesencephalon contains both neurotensin and cholecystokinin. Brain Res. 455:1989;88-98.
51. Sonsalla P.K., Youngster S.K., Kindt M.V., Heikkila R.E. N-Methyl-4-(2′-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Pharmac. exp. Ther. 242:1987;850-855.
52. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:1982;321-353.
53. Taketo M., Schroeder A.C., Mobraaten L.E., Gunning K.B., Hanten G., Fox R.R., Roderick T.H., Stewart C.L., Lilly F., Hansen C.T., Overbeek P.A. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc. natn. Acad. Sci. U.S.A. 88:1991;2065-2069.
54. 28k. Brain Res. 526:1990;303-307.